Co-founder and CEO announced he will step down from his role and the board by the end of 2026.

: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas.

: Continued advancement in national programs like NIHR Bioresource. Strategic and Operational Developments